Skip to main content
. 2021 Sep 29;61(1):5–18. doi: 10.1002/mc.23355

Figure 1.

Figure 1

Decision curve analyses (DCA) for the evaluation of the clinical net‐benefit using the log models for the prediction of (A) lymph node metastasis, (B) ≥ pT3 disease, and (C) any nonorgan confined disease